The IL-10 (-627 A/C) Promoter Polymorphism May Be Associated With Coronary Aneurysms and Low Serum Albumin in Korean Children With Kawasaki Disease

Pediatric Research

Volumn 61, Issue 5, 2007, Pages 584-587

  Jin, Hyun Seung ^a   Kim, Hyo Bin ^b   Kim, Bong Seong ^a   Lee, Jong Keuk ^a   Seo, Eul Ju ^a   Yoo, Han Wook ^a   Park, In Sook ^a   Hong, Young Mi ^c   Hong, Soo Jong ^a  

^a University of Ulsan College of Medicine   (South Korea)

^b Inje University College of Medicine   (South Korea)

^c Ewha Womans University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; INTERLEUKIN 10;

ALBUMIN BLOOD LEVEL; ALLELE; ARTICLE; CONFIDENCE INTERVAL; CONGENITAL HEART DISEASE; CONTROLLED STUDY; CORONARY ARTERY ANEURYSM; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC MARKER; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HUMAN; KOREA; MAJOR CLINICAL STUDY; MALE; MEDICAL PARAMETERS; MUCOCUTANEOUS LYMPH NODE SYNDROME; PRESCHOOL CHILD; PRIORITY JOURNAL; PROMOTER REGION;

ASIAN CONTINENTAL ANCESTRY GROUP; CHILD, PRESCHOOL; CORONARY ANEURYSM; FEMALE; GENE FREQUENCY; HUMANS; INTERLEUKIN-10; KOREA; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); SERUM ALBUMIN;

EID: 34247514244     PISSN: 00313998     EISSN: 15300447     Source Type: Journal    
DOI: 10.1203/pdr.0b013e3180459fb5     Document Type: Article

References (43)

1. Burns JC, Glode MP 2004 Kawasaki syndrome. Lancet 364:533-544.
2. Hirose S, Hamashima Y 1978 Morphological observations on the vasculitis in the mucocutaneous lymph node syndrome. A skin biopsy study of 27 patients. Eur J Pediatr 129:17-27.
3. Suzuki A, Kamiya T, Kuwahara N, Ono Y, Kohata T, Takahashi O, Kimura K, Takamiya M 1986 Coronary arterial lesions of Kawasaki disease: cardiac catheterization findings of 1100 cases. Pediatr Cardiol 7:3-9.
4. Akagi T, Kato H, Inoue O, Sato N, Imamura K 1990 Valvular heart disease in Kawasaki syndrome: incidence and natural history. Am Heart J 120:366-372.
5. Kato H, Sugimura T, Akagi T, Sato N, Hashino K, Maeno Y, Kazue T, Eto G, Yamakawa R 1996 Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients. Circulation 94:1379-1385.
6. Jibiki T, Terai M, Shima M, Ogawa A, Hamada H, Kanazawa M, Yamamoto S, Oana S, Kohno Y 2001 Monocyte chemoattractant protein 1 gene regulatory region polymorphism and serum levels of monocyte chemoattractant protein 1 in Japanese patients with Kawasaki disease. Arthritis Rheum 44:2211-2212.
7. Tsukahara H, Hiraoka M, Saito M, Nishda K, Kobata R, Tshchida S, Toyooka M, Kimura H, Gejyo F, Mayumi M 2000 Methylenetetrahydrofolate reductase polymorphism in Kawasaki disease. Pediatr Int 42:236-240.
8. Takeuchi K, Yamamoto K, Kataoka S, Kakihara T, Tanaka A, Sato S, Uchiyama M 1997 High incidence of angiotensin I converting enzyme genotype II in Kawasaki disease patients with coronary aneurysm. Eur J Pediatr 156:266-268.
9. Ouchi K, Suzuki Y, Shirakawa T, Kishi F 2003 Polymorphism of SLC11A1(formerly NRAMP1) gene confers susceptibility to Kawasaki disease. J Infect Dis 187:326-329.
10. Wu SF, Chang JS, Wan L, Tsai CH, Tsai FJ 2005 Association of IL-1Ra gene polymorphism, but no association of IL-1beta and IL-4 gene polymorphisms, with Kawasaki disease. J Clin Lab Anal 19:99-102.
11. Biezeveld MH, Geissler J, Weverling GJ, Kuipers IM, Lam J, Ottenkamp J, Kuijpers TW 2006 Polymorphisms in the mannose-binding lectin gene as determinants of age-defined risk of coronary artery lesions in Kawasaki disease. Arthritis Rheum 54:369-376.
12. Kariyazono H, Ohno T, Khajoee V, Ihara K, Kusuhara K, Kinukawa N, Mizuno Y, Hara T 2004 Association of vascular endothelial growth factor (VEGF) and VEGF receptor gene polymorphisms with coronary artery lesions of Kawasaki disease. Pediatr Res 56:953-959.
13. Nishimura S, Zaitsu M, Hara M, Yokota G, Watanabe M, Ueda Y, Imayoshi M, Ishii E, Tasaki H, Hamasaki Y 2003 A polymorphism in the promoter of the CD14 gene (CD14/-159) is associated with the development of coronary artery lesions in patients with Kawasaki disease. J Pediatr 143:357-362.
14. Nishimura S, Zaitsu M, Hara M, Yokota G, Watanabe M, Ueda Y, Imayoshi M, Ishii E, Tasaki H, Hamasaki Y 2003 A polymorphism in the promoter of the CD14 gene (CD14/-159) is associated with the development of coronary artery lesions in patients with Kawasaki disease. J Pediatr 143:357-362.
15. Park JA, Shin KS, Kim YW 2005 Polymorphism of matrix metalloproteinase 3 promoter gene as a risk factor for coronary artery lesions in Kawasaki disease. J Korean Med Sci 20:607-611.
16. Furukawa S, Matsubara T, Jujoh K, Yone K, Sugawara T, Sasai K, Kato H, Yabuta K 1988 Peripheral blood monocyte/macrophage and serum tumor necrosis factor in Kawasaki disease. Clin Immunol Immunopathol 48:247-251.
17. Matsubara T, Furukawa S, Yabuta K 1990 Serum levels of tumor necrosis factor, interleukin 2 receptor, and interferon gamma in Kawasaki disease involved coronary artery lesions. Clin Immunol Immunopathol 56:29-36.
18. Maury CP, Salo E, Pelkonen P 1988 Circulating interleukin-1 in patients with Kawasaki disease. N Engl J Med 319:1670-1671.
19. Ueno Y, Takano N, Kanegane H, Yokoi T, Yachie A, Miyawaki T, Taniguchi N 1989 The acute phase nature of interleukin 6: studied in Kawasaki disease and other febrile illness. Clin Exp Immunol 76:337-342.
20. Eberhard BA, Andersson U, Laxer RM, Rose R, Silverman ED 1995 Evaluation of the cytokine response in Kawasaki disease. Pediatr Infect Dis J 14:199-203.
21. Kim DS, Lee HK, Noh GW, Lee SI, Lee KY 1996 Increased serum interleukin-10 level in Kawasaki disease. Yonsei Med J 37:125-130.
22. Hirao J, Hibi S, Andoh T, Ichimura T 1997 High levels of circulating interleukin-4 and interleukin-10 in Kawasaki disease. Int Arch Allergy Immunol 112:152-156.
23. Noh GW, Lee WG, Lee W, Lee K 1998 Effects of intravenous immunoglobulin on plasma interleukin-10 levels in Kawasaki disease. Immunol Lett 62:19-24.
24. Okada Y, Shinohara M, Kobayashi T, Inoue Y, Tomomasa T, Kobayashi T, Morikawa A. The Gunma Kawasaki Disease Study Group 2003 Effect of corticosteroids in addition to intravenous gamma globulin therapy on serum cytokine levels in the acute phase of Kawasaki disease in children. J Pediatr 143:363-367.
25. Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV 1997 An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 24:1-8.
26. Eskdale J, Kube D, Tesch H, Gallagher G 1997 Mapping of the human IL10 gene and further characterization of the 5′ flanking sequence. Immunogenetics 46:120-128.
27. Eskdale J, Gallagher G, Verweij CL, Keijsers V, Westendorp RG, Huizinga TW 1998 Interleukin 10 secretion in relation to human IL-10 locus haplotypes. Proc Natl Acad Sci U S A 95:9465-9470.
28. Hajeer AH, Lazarus M, Turner D, Mageed RA, Vencovsky J, Sinnott P, Hutchinson IV, Ollier WE 1998 IL-10 gene promoter polymorphisms in rheumatoid arthritis. Scand J Rheumatol 27:142-145.
29. Grove J, Daly AK, Bassendine MF, Gilvarry E, Day CP 2000 Interleukin 10 promoter region polymorphisms and susceptibility to advanced alcoholic liver disease. Gut 46:540-545.
30. Lazarus M, Hajeer AH, Turner D, Sinnott P, Worthington J, Ollier WE, Hutchinson IV 1997 Genetic variation in the interleukin 10 gene promoter and systemic lupus erythematosus. J Rheumatol 24:2314-2317.
31. Rosenwasser LJ, Borish L 1997 Genetics of atopy and asthma: the rationale behind promoter-based candidate gene studies (IL-4 and IL-10). Am J Respir Crit Care Med 156:S152-S155.
32. Hobbs K, Negri J, Klinnert M, Rosenwasser LJ, Borish L 1998 Interleukin-10 and transforming growth factor-beta promoter polymorphisms in allergies and asthma. Am J Respir Crit Care Med 158:1958-1962.
33. Wu KH, Peng CT, Li TC, Wan L, Tsai CH, Lan SJ, Chang MC, Tsai FJ 2005 Interleukin 4, interleukin 6 and interleukin 10 polymorphisms in children with acute and chronic immune thrombocytopenic purpura. Br J Haematol 128:849-852.
34. Koren G, Lavi S, Rose V, Rowe R 1986 Kawasaki disease: review of risk factors for coronary aneurysms. J Pediatr 108:388-392.
35. Beiser AS, Takahashi M, Baker AL, Sundel RP, Newburger JW 1998 A predictive instrument for coronary artery aneurysms in Kawasaki disease. Am J Cardiol 81:1116-1120.
36. Mori M, Imagawa T, Yasui K, Kanaya A, Yokota S 2000 Predictors of coronary artery lesions after intravenous gamma globulin treatment in Kawasaki disease. J Pediatr 137:177-180.
37. Morikawa Y, Ohashi Y, Harada K, Asai T, Okawa S, Nagashima M, Katoh T, Baba K, Furusho K, Okuni M, Osano M 2000 Coronary risks after high dose gamma globulin in children with Kawasaki disease. Pediatr Int 42:464-469.
38. Honkanen VE, McCrindle BW, Laxer RM, Feldman BM, Schneider R, Silverman ED 2003 Clinical relevance of the risk factors for coronary artery inflammation in Kawasaki disease. Pediatr Cardiol 24:122-126.
39. Terai M, Honda T, Yasukawa K, Higashi K, Hamada H, Kohno Y 2003 Prognostic impact of vascular leakage in acute Kawasaki disease. Circulation 108:325-330.
40. van Eijk LT, Nooteboom A, Hendriks T, Sprong T, Netea MG, Smits P, van der Hoeven JG, Pickkers P 2006 Plasma obtained during human endotoxemia increases endothelial albumin permeability in vitro. Shock 25:358-362.
41. Wang Q, Fang Ch, Hasselgren PO 2001 Intestinal permeability is reduced and IL-10 levels are increased in septic IL-6 knockout mice. Am J Physiol Regul Integr Comp Physiol 281:R1013-R1023.
42. Hickey MJ, Issekutz AC, Reinhardt PH, Fedorak RN, Kubes P 1998 Endogenous interleukin-10 regulates hemodynamic parameters, leukocyte-endothelial cell interactions, and microvascular permeability during endotoxemia. Circ Res 83:1124-1131.
43. Dewi BE, Takasaki T, Kurane I 2004 In vitro assessment of human endothelial cell permeability: effects of inflammatory cytokines and dengue virus infection. J Virol Methods 121:171-180.